Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17250
Corporate User License Price USD 750
Corporate User License Price INR 51750
Site License Price USD 500
Site License Price INR 34500
Request a Quote

Report Title

bioMerieux SA (BIM) - Medical Equipment - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

bioMerieux SA (BIM) - Medical Equipment - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

bioMerieux SA (BIM) - Medical Equipment - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

bioMerieux SA (BIM) - Medical Equipment - Deals and Alliances Profile



Executive Summary

Summary

bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures and markets in vitro diagnostic solutions for private and hospital laboratories. The company offers diagnostic solutions such as systems, reagents and software. Its products are used to diagnose infectious diseases, cardiovascular diseases and targeted cancers. The company also provides solutions for the enumeration of microbial flora, to detect specific pathogenic bacteria, and to monitor air and surface quality and sterility testing for agri-food, cosmetics and pharmaceutical industries. The company distributes its products directly and also through a network of distributors across the world. bioMerieux is headquartered in Marcy l'Etoile, France.

bioMerieux SA (BIM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

bioMerieux SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

bioMerieux SA, Medical Equipment Deals By Type, 2012 to YTD 2018 8

bioMerieux SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

bioMerieux SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

bioMerieux SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

bioMerieux SA, Medical Equipment, Deal Details 13

Venture Financing 13

Qvella Raises USD20 Million in Series B Financing 13

Astute Medical Raises Additional USD1 Million in Venture Financing 15

Astute Medical Raises USD2 Million in Venture Financing 16

Astute Medical Raises USD20 Million in Venture Financing 17

Astute Medical Secures USD40 Million in Venture Funding from CRG (Capital Royalty) 18

Astute Medical Raises USD20 Million in Venture Financing 19

Quanterix Raises USD 19 Million In Series C Financing 20

BioFire Diagnostics Raises USD25 Million in Financing Round 22

Astute Medical Raises USD 40.4 Million In Series C Financing 23

Astute Medical Raises USD 2 Million In Venture Financing 25

Private Equity 26

BioTheranostics Raises USD32 Million in Private Equity Financing 26

Athyrium Opportunities Fund Invests USD 20 Million In BioFire Diagnostics 27

Partnerships 28

Quanterix Enters into Licensing Agreement with bioMerieux 28

BioMerieux Enters into Licensing Agreement with Astute Medical 29

Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 30

Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 31

bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 32

Astute Medical Enters into Distribution Agreement with bioMerieux 33

Biomerieux Enters into Agreement with Banyan Biomarkers 34

ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 35

Biotheranostics Enters into Agreement with Syapse 36

BioMerieux Enters into Co-Development Agreement with Copan Italia 37

BioMerieux Enters into Distribution Agreement with Copan 38

Astute Medical Enters into Distribution Agreement with Fosun Long March 39

BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 40

BioMerieux Enters into Co-Development Agreement with Illumina 41

Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 42

PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 43

OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 44

Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 45

Equity Offering 46

Astute Medical Raises USD43 Million in Private Palcement of Shares 46

Debt Offering 47

bioMerieux Completes Private Placement Of Bonds Due 2020 For USD 406.6 Million 47

Acquisition 48

bioMerieux Acquires Astute Medical for USD90 Million 48

bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 49

BioMerieux Acquires Applied Maths 50

BioMerieux Completes Acquisition Of BioFire Diagnostics For USD 486 Million 51

bioMerieux SA-Key Competitors 53

bioMerieux SA-Key Employees 54

bioMerieux SA-Locations And Subsidiaries 56

Head Office 56

Other Locations & Subsidiaries 56

Recent Developments 60

Financial Announcements 60

Apr 19, 2018: biomerieux-First-quarter 2018 Business Review 60

Jan 23, 2018: bioMerieux-Fourth-Quarter 2017 Business Review 62

Aug 30, 2017: bioMerieux-First-Half 2017 Results 65

Jul 20, 2017: bioMerieux-Second-Quarter 2017 Business Review 68

Apr 20, 2017: bioMerieux-First-Quarter 2017 Business Review 70

Mar 01, 2017: bioMerieux-2016 Financial Results 73

Jan 19, 2017: bioMerieux-Fourth-Quarter 2016 Business Review 76

Corporate Communications 78

Apr 23, 2018: bioMerieux and the University of Antwerp award scholarships to three healthcare professionals for their commitment to improve antibiotic use in order to combat antimicrobial resistance 78

Product News 79

Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference 79

Other Significant Developments 80

Oct 18, 2017: bioMerieux-Business review for the nine months ended September 30, 2017 80

Appendix 82

Methodology 82

About GlobalData 82

Contact Us 82

Disclaimer 82

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

bioMerieux SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

bioMerieux SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

bioMerieux SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

bioMerieux SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

bioMerieux SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

bioMerieux SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

bioMerieux SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

bioMerieux SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

List of Tables

bioMerieux SA, Medical Equipment, Key Facts, 2017 2

bioMerieux SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

bioMerieux SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

bioMerieux SA, Medical Equipment Deals By Type, 2012 to YTD 2018 8

bioMerieux SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

bioMerieux SA, Deals By Market, 2012 to YTD 2018 10

bioMerieux SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Qvella Raises USD20 Million in Series B Financing 13

Astute Medical Raises Additional USD1 Million in Venture Financing 15

Astute Medical Raises USD2 Million in Venture Financing 16

Astute Medical Raises USD20 Million in Venture Financing 17

Astute Medical Secures USD40 Million in Venture Funding from CRG (Capital Royalty) 18

Astute Medical Raises USD20 Million in Venture Financing 19

Quanterix Raises USD 19 Million In Series C Financing 20

BioFire Diagnostics Raises USD25 Million in Financing Round 22

Astute Medical Raises USD 40.4 Million In Series C Financing 23

Astute Medical Raises USD 2 Million In Venture Financing 25

BioTheranostics Raises USD32 Million in Private Equity Financing 26

Athyrium Opportunities Fund Invests USD 20 Million In BioFire Diagnostics 27

Quanterix Enters into Licensing Agreement with bioMerieux 28

BioMerieux Enters into Licensing Agreement with Astute Medical 29

Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 30

Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 31

bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 32

Astute Medical Enters into Distribution Agreement with bioMerieux 33

Biomerieux Enters into Agreement with Banyan Biomarkers 34

ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 35

Biotheranostics Enters into Agreement with Syapse 36

BioMerieux Enters into Co-Development Agreement with Copan Italia 37

BioMerieux Enters into Distribution Agreement with Copan 38

Astute Medical Enters into Distribution Agreement with Fosun Long March 39

BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 40

BioMerieux Enters into Co-Development Agreement with Illumina 41

Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 42

PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 43

OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 44

Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 45

Astute Medical Raises USD43 Million in Private Palcement of Shares 46

bioMerieux Completes Private Placement Of Bonds Due 2020 For USD 406.6 Million 47

bioMerieux Acquires Astute Medical for USD90 Million 48

bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 49

BioMerieux Acquires Applied Maths 50

BioMerieux Completes Acquisition Of BioFire Diagnostics For USD 486 Million 51

bioMerieux SA, Key Competitors 53

bioMerieux SA, Key Employees 54

bioMerieux SA, Subsidiaries 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

bioMerieux SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person